163 related articles for article (PubMed ID: 29264528)
1. Combined Hormonal Contraceptives and First Venous Thrombosis in Young French Women: Impact of Thrombotic Family History.
Hugon-Rodin J; Horellou MH; Conard J; Gompel A; Plu-Bureau G
J Endocr Soc; 2017 Jun; 1(6):762-771. PubMed ID: 29264528
[TBL] [Abstract][Full Text] [Related]
2. First venous thromboembolism and hormonal contraceptives in young French women.
Hugon-Rodin J; Horellou MH; Conard J; Flaujac C; Gompel A; Plu-Bureau G;
Medicine (Baltimore); 2017 Aug; 96(34):e7734. PubMed ID: 28834877
[TBL] [Abstract][Full Text] [Related]
3. Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
Hugon-Rodin J; Horellou MH; Conard J; Gompel A; Plu-Bureau G
Thromb Haemost; 2018 May; 118(5):922-928. PubMed ID: 29614525
[TBL] [Abstract][Full Text] [Related]
4. Hormone-dependent gynaecological disorders and contraceptive modalities in women with a history of venous thromboembolic event: The THROMBOGYN study.
Mottais-Cosnefroy V; Pecourt M; Yannoutsos A; Fels A; Beaussier H; Alran S; Priollet P; Hugon-Rodin J
J Med Vasc; 2022; 47(5-6):228-237. PubMed ID: 36464417
[TBL] [Abstract][Full Text] [Related]
5. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
Dragoman M; Curtis KM; Gaffield ME
Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
[TBL] [Abstract][Full Text] [Related]
6. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Plu-Bureau G; Sabbagh E; Hugon-Rodin J
Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
[TBL] [Abstract][Full Text] [Related]
7. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
8. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
Horton LG; Simmons KB; Curtis KM
Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
[TBL] [Abstract][Full Text] [Related]
9. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
[TBL] [Abstract][Full Text] [Related]
10. Combined hormonal contraceptives use among women with contraindications according to the WHO criteria: A systematic review.
Houvèssou GM; Farías-Antúnez S; da Silveira MF
Sex Reprod Healthc; 2021 Feb; 27():100587. PubMed ID: 33545506
[TBL] [Abstract][Full Text] [Related]
11. Inappropriate use of combined hormonal contraceptives for birth control among women of reproductive age in the United States.
Yu J; Hu XH
J Womens Health (Larchmt); 2013 Jul; 22(7):595-603. PubMed ID: 23789583
[TBL] [Abstract][Full Text] [Related]
12. Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.
Lauring JR; Lehman EB; Deimling TA; Legro RS; Chuang CH
Am J Obstet Gynecol; 2016 Sep; 215(3):330.e1-7. PubMed ID: 27059507
[TBL] [Abstract][Full Text] [Related]
13. [Hormonal contraception and vascular risk].
Plu-Bureau G; Hugon-Rodin J; Raccah-Tebeka B
Rev Prat; 2018 Apr; 68(4):394-400. PubMed ID: 30869386
[TBL] [Abstract][Full Text] [Related]
14. Medical contraindications in women seeking combined hormonal contraception.
Xu H; Eisenberg DL; Madden T; Secura GM; Peipert JF
Am J Obstet Gynecol; 2014 Mar; 210(3):210.e1-5. PubMed ID: 24246525
[TBL] [Abstract][Full Text] [Related]
15. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
Farmer RD; Todd JC; Lewis MA; MacRae KD; Williams TJ
Contraception; 1998 Feb; 57(2):67-70. PubMed ID: 9589831
[TBL] [Abstract][Full Text] [Related]
16. Superficial venous disease and combined hormonal contraceptives: a systematic review.
Tepper NK; Marchbanks PA; Curtis KM
Contraception; 2016 Sep; 94(3):275-9. PubMed ID: 25835269
[TBL] [Abstract][Full Text] [Related]
17. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in women: a specific reproductive health risk.
ESHRE Capri Workshop Group
Hum Reprod Update; 2013; 19(5):471-82. PubMed ID: 23825156
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross-sectional observational study in 30 French public hospitals.
Gourbil M; Grandvuillemin A; Beyens MN; Massy N; Gras V; D'Amico A; Miremont-Salamé G; Petitpain N;
Drug Saf; 2014 Apr; 37(4):269-82. PubMed ID: 24634164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
